These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 4168734)
1. Some clinical aspects and treatment of anonymous mycobacterial infections. Davey ME Med J Aust; 1967 Sep; 2(10):438-41. PubMed ID: 4168734 [No Abstract] [Full Text] [Related]
2. [Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig]. Tacquet A; Devulder B; Tison F; Martin JC Antibiot Chemother; 1970; 16():160-76. PubMed ID: 5535612 [No Abstract] [Full Text] [Related]
3. [Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)]. Yamaguchi T; Toyohara M Kekkaku; 1967 Jul; 42(7):245-50. PubMed ID: 5583607 [No Abstract] [Full Text] [Related]
4. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]. Chioléro R Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521 [No Abstract] [Full Text] [Related]
6. Diagnosis and management of tuberculosis. Harris AA; Karakusis P Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269 [No Abstract] [Full Text] [Related]
7. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report. Elston HR; Duffy JP Am Rev Respir Dis; 1973 Oct; 108(4):944-9. PubMed ID: 4582438 [No Abstract] [Full Text] [Related]
8. Rifampicin, myambutol, Isoxyl, and capreomycin as combination partners in animal experiments. Rosenfeld M Antibiot Chemother; 1970; 16():501-15. PubMed ID: 4108897 [No Abstract] [Full Text] [Related]
9. Status of mycobacterial infections of the lungs. Savacool JW Ann Clin Lab Sci (1971); 1973; 3(2):91-7. PubMed ID: 4575158 [No Abstract] [Full Text] [Related]
10. [Comparative data from an experimental-clinical study of new antituberculosis drugs]. Utkin VV Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726 [No Abstract] [Full Text] [Related]
11. Pulmonary disease caused by Mycobacterium xenopi:two case reports. Tellis CJ; Beechler CR; Ohashi DK; Fuller SA Am Rev Respir Dis; 1977 Oct; 116(4):779-83. PubMed ID: 335935 [TBL] [Abstract][Full Text] [Related]
12. [Isoxyl and T283 in the treatment of photochromogenic infections in mice]. Burjanová B; Dornetzhuber V Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189 [No Abstract] [Full Text] [Related]
13. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide]. Favez G; Willa C Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721 [No Abstract] [Full Text] [Related]
14. Activity of certain antibacillary substances in the experimental infection of guinea-pigs exposed to dust by Mycobacterium kansasii. Tacquet A; Collet A; Devulder B; Martin JC Z Tuberk Erkr Thoraxorg; 1967; 127(1):127-31. PubMed ID: 5632591 [No Abstract] [Full Text] [Related]
15. The treatment of tuberculosis and mycobacterial pulmonary disease. Savacool JW Del Med J; 1971 Nov; 43(11):320-6. PubMed ID: 5122243 [No Abstract] [Full Text] [Related]
16. Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis. Kittel H Antibiot Chemother; 1970; 16():36-42. PubMed ID: 4108894 [No Abstract] [Full Text] [Related]
20. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin]. Daddi G Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324 [No Abstract] [Full Text] [Related] [Next] [New Search]